PUBLISHER: Polaris Market Research | PRODUCT CODE: 1463119
PUBLISHER: Polaris Market Research | PRODUCT CODE: 1463119
North America Tumor Ablation Market Share, Size, Trends, Industry Analysis Report, By Technology (Radiofrequency (RF) Ablation, Microwave Ablation, Cryoablation, Others); By Mode of Treatment; By Application; By Region; Segment Forecast, 2024 - 2032
The North America tumor ablation market size is expected to reach USD 2.12 Billion by 2032, according to a new study by Polaris Market Research. The report "North America Tumor Ablation Market Share, Size, Trends, Industry Analysis Report, By Technology (Radiofrequency (RF) Ablation, Microwave Ablation, Cryoablation, Others); By Mode of Treatment; By Application; By Region; Segment Forecast, 2024 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.
The market for tumor ablation in North America is experiencing significant growth, mainly due to the increasing preference of both patients and surgeons toward minimally invasive procedures. This change is reshaping the landscape of cancer treatment, as these procedures offer numerous advantages over traditional surgical methods. Minimally invasive tumor ablation techniques, such as radiofrequency ablation, microwave ablation, and cryoablation, are gaining widespread acceptance due to their reduced invasiveness, shorter recovery times, and lower post-operative complications. These techniques also allow for targeted treatment, resulting in less damage to surrounding healthy tissue. Additionally, the rising prevalence of cancer and advancements in technology are further driving the growth of the tumor ablation market in North America.
Tumor ablation is a non-surgical, image-guided procedure in which interventional radiologists precisely target and then reduce or eliminate a tumor using either intense heat or cold. The big companies operating in tumor ablation therapy devices are concentrating on technological advancements for shorter procedures, lower exposure to radiation, and quicker learning curves, elevating safety. The tumor ablation market in North America is expected to grow due to the rising demand for minimally invasive procedures. These techniques involve the use of specialized instruments and technology, which help reduce the size of incisions, resulting in minimal disruption to the patient's body.
North America focused on developing minimally invasive techniques and increasing precision in cancer treatment. Radiofrequency ablation (RFA), microwave ablation (MWA), and cryoablation have gained popularity due to their ability to target tumors with minimal damage to surrounding healthy tissue. Furthermore, there was growing interest in combining ablation techniques with advanced imaging technologies and real-time monitoring to improve accuracy and effectiveness. These advancements in ablation techniques have led to improved patient outcomes and reduced recovery times. Additionally, ongoing research and development in North America are also exploring the potential of using ablation techniques in combination with immunotherapy to enhance the body's immune response against cancer cells.
North America Tumor Ablation Market Report Highlights
The radiofrequency ablation segment held the largest market share in North America. It is extensively used in treating numerous types of cancer types, like kidney, lung, liver, and bone tumors.
The percutaneous ablation segment held the highest market share in North America. Percutaneous ablation provides better security, fast recovery, and less scarring.
Canada is anticipated to hold the fastest growth over the forecast period due to the increasing burden of cancer and the increasing cancer occurrence rate, which is 296.6 cases per 1,00,000 people every year.
The key market players include AngioDynamics Inc., Bioventus Inc., Boston Scientific Corp., EDAP TMS S.A., Galil Medical Inc., HealthTronics, Medtronic Plc., Mermaid Medical, Misonix, Inc., Neuwave Medical, Inc., and SonaCare Medical.
Polaris Market Research has segmented the North America tumor ablation market report based on technology, mode of treatment, application, and country:
North America Tumor Ablation, Technology Outlook (Revenue - USD Billion, 2019 - 2032)
- Radiofrequency (RF) Ablation
- Microwave Ablation
- Cryoablation
- Others
North America Tumor Ablation, Mode of Treatment Outlook (Revenue - USD Billion, 2019 - 2032)
- Surgical Ablation
- Laparoscopic Ablation
- Percutaneous Ablation
North America Tumor Ablation, Application Outlook (Revenue - USD Billion, 2019 - 2032)
- Liver Cancer
- Lung Cancer
- Kidney Cancer
- Bone Metastasis
- Others
North America Tumor Ablation, Country Outlook (Revenue - USD Billion, 2019 - 2032)
- U.S.
- Canada
Table of Contents
1. Introduction
- 1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
- 1.2. Stakeholders
2. Executive Summary
- 2.1. Market Highlights
3. Research Methodology
- 3.1. Overview
- 3.1.1. Data Mining
- 3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources
4. North America Tumor Ablation Market Insights
- 4.1. North America Tumor Ablation Market - Industry Snapshot
- 4.2. North America Tumor Ablation Market Dynamics
- 4.2.1. Drivers and Opportunities
- 4.2.1.1. Increasing prevalence of cancer will drive the growth of the market
- 4.2.1.2. Increasing inclination of patients and surgeons towards minimally invasive procedures will foster the market growth
- 4.2.2. Restraints and Challenges
- 4.2.2.1. High cost associated with tumor ablation procedures hindering the growth of the market
- 4.2.1. Drivers and Opportunities
- 4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
- 4.4. PESTLE Analysis
- 4.5. North America Tumor Ablation Industry trends
- 4.6. Value Chain Analysis
- 4.7. COVID-19 Impact Analysis
5. North America Tumor Ablation Market, by Technology
- 5.1. Key Findings
- 5.2. Introduction
- 5.2.1. North America Tumor Ablation, by Technology, 2019-2032 (USD Billion)
- 5.3. Radiofrequency (RF) Ablation
- 5.3.1. North America Tumor Ablation Market, by Radiofrequency (RF) Ablation, 2019-2032 (USD Billion)
- 5.4. Microwave Ablation
- 5.4.1. North America Tumor Ablation Market, by Microwave Ablation, 2019-2032 (USD Billion)
- 5.5. Cryoablation
- 5.5.1. North America Tumor Ablation Market, by Cryoablation, 2019-2032 (USD Billion)
- 5.6. Others
- 5.6.1. North America Tumor Ablation Market, by Others, 2019-2032 (USD Billion)
6. North America Tumor Ablation Market, by Application
- 6.1. Key Findings
- 6.2. Introduction
- 6.2.1. North America Tumor Ablation Market, by Application, 2019-2032 (USD Billion)
- 6.3. Liver Cancer
- 6.3.1. North America Tumor Ablation Market, by Liver Cancer, 2019-2032 (USD Billion)
- 6.4. Lung Cancer
- 6.4.1. North America Tumor Ablation Market, by Lung Cancer, 2019-2032 (USD Billion)
- 6.5. Kidney Cancer
- 6.5.1. North America Tumor Ablation Market, by Kidney Cancer, 2019-2032 (USD Billion)
- 6.6. Bone Metastasis
- 6.6.1. North America Tumor Ablation Market, by Bone Metastasis, 2019-2032 (USD Billion)
- 6.7. Others
- 6.7.1. North America Tumor Ablation Market, by Others, 2019-2032 (USD Billion)
7. North America Tumor Ablation Market, by Mode of Treatment
- 7.1. Key Findings
- 7.2. Introduction
- 7.2.1. North America Tumor Ablation Market, by Mode of Treatment, 2019-2032 (USD Billion)
- 7.3. Surgical Ablation
- 7.3.1. North America Tumor Ablation Market, by Surgical Ablation, 2019-2032 (USD Billion)
- 7.4. Laparoscopic Ablation
- 7.4.1. North America Tumor Ablation Market, by Laparoscopic Ablation, 2019-2032 (USD Billion)
- 7.5. Percutaneous Ablation
- 7.5.1. North America Tumor Ablation Market, by Percutaneous Ablation, 2019-2032 (USD Billion)
8. North America Tumor Ablation Market, by Countries
- 8.1. Key findings
- 8.2. Introduction
- 8.2.1. North America Tumor Ablation Market Assessment, By Countries, 2019-2032 (USD Billion)
- 8.2.2. North America Tumor Ablation Market - U.S.
- 8.2.2.1. U.S.: North America Tumor Ablation Market, by Application, 2019-2032 (USD Billion)
- 8.2.2.2. U.S.: North America Tumor Ablation Market, by Technology, 2019-2032 (USD Billion)
- 8.2.2.3. U.S.: North America Tumor Ablation Market, by Mode of Treatment, 2019-2032 (USD Billion)
- 8.2.3. North America Tumor Ablation Market - Canada
- 8.2.3.1. Canada.: North America Tumor Ablation Market, by Application, 2019-2032 (USD Billion)
- 8.2.3.2. Canada.: North America Tumor Ablation Market, by Technology, 2019-2032 (USD Billion)
- 8.2.3.3. Canada.: North America Tumor Ablation Market, by Mode of Treatment, 2019-2032 (USD Billion)
9. Competitive Landscape
- 9.1. Expansion and Acquisition Analysis
- 9.1.1. Expansion
- 9.1.2. Acquisitions
- 9.2. Partnerships/Collaborations/Agreements/Exhibitions
10. Company Profiles
- 10.1. AngioDynamics Inc.
- 10.1.1. Company Overview
- 10.1.2. Financial Performance
- 10.1.3. Technology Benchmarking
- 10.1.4. Recent Development
- 10.2. Bioventus Inc.
- 10.2.1. Company Overview
- 10.2.2. Financial Performance
- 10.2.3. Technology Benchmarking
- 10.2.4. Recent Development
- 10.3. Boston Scientific Corp.
- 10.3.1. Company Overview
- 10.3.2. Financial Performance
- 10.3.3. Technology Benchmarking
- 10.3.4. Recent Development
- 10.4. EDAP TMS S.A.
- 10.4.1. Company Overview
- 10.4.2. Financial Performance
- 10.4.3. Technology Benchmarking
- 10.4.4. Recent Development
- 10.5. Galil Medical Inc.
- 10.5.1. Company Overview
- 10.5.2. Financial Performance
- 10.5.3. Technology Benchmarking
- 10.5.4. Recent Development
- 10.6. HealthTronics
- 10.6.1. Company Overview
- 10.6.2. Financial Performance
- 10.6.3. Technology Benchmarking
- 10.6.4. Recent Development
- 10.7. Medtronic Plc.
- 10.7.1. Company Overview
- 10.7.2. Financial Performance
- 10.7.3. Technology Benchmarking
- 10.7.4. Recent Development
- 10.8. Mermaid Medical
- 10.8.1. Company Overview
- 10.8.2. Financial Performance
- 10.8.3. Technology Benchmarking
- 10.8.4. Recent Development
- 10.9. Misonix, Inc.
- 10.9.1. Company Overview
- 10.9.2. Financial Performance
- 10.9.3. Technology Benchmarking
- 10.9.4. Recent Development
- 10.10. Neuwave Medical, Inc.
- 10.10.1. Company Overview
- 10.10.2. Financial Performance
- 10.10.3. Technology Benchmarking
- 10.10.4. Recent Development
- 10.11. SonaCare Medical
- 10.11.1. Company Overview
- 10.11.2. Financial Performance
- 10.11.3. Technology Benchmarking
- 10.11.4. Recent Development
List of Tables
- Table 1 North America Tumor Ablation Market, by Application, 2019-2032 (USD Billion)
- Table 2 North America Tumor Ablation Market, by Technology, 2019-2032 (USD Billion)
- Table 3 North America Tumor Ablation Market, by Mode of Treatment, 2019-2032 (USD Billion)
- Table 4 North America Tumor Ablation Market Assessment, By Countries, 2019-2032 (USD Billion)
- Table 5 U.S.: North America Tumor Ablation Market, by Application, 2019-2032 (USD Billion)
- Table 6 U.S.: North America Tumor Ablation Market, by Technology, 2019-2032 (USD Billion)
- Table 7 U.S.: North America Tumor Ablation Market, by Mode of Treatment, 2019-2032 (USD Billion)
- Table 8 Canada.: North America Tumor Ablation Market, by Application, 2019-2032 (USD Billion)
- Table 9 Canada.: North America Tumor Ablation Market, by Technology, 2019-2032 (USD Billion)
- Table 10 Canada.: North America Tumor Ablation Market, by Mode of Treatment, 2019-2032 (USD Billion)
List of Figures
- Figure 1 North America Tumor Ablation Market, 2019-2032 (USD Billion)
- Figure 2 Integrated Ecosystem
- Figure 3 Research Methodology: Top-Down & Bottom-Up Approach
- Figure 4 Market by Countries
- Figure 5 Porter's Five Forces
- Figure 6 Market by Application
- Figure 7 North America Tumor Ablation Market, by Application, 2021 & 2030 (USD Billion)
- Figure 8 Market by Technology
- Figure 9 North America Tumor Ablation Market, by Technology, 2021 & 2030 (USD Billion)
- Figure 10 Market by Mode of Treatment
- Figure 11 North America Tumor Ablation Market, by Mode of Treatment, 2021 & 2030 (USD Billion)
- Figure 12 North America Tumor Ablation Market Assessment, By Countries, 2019-2032 (USD Billion)
- Figure 13 Strategic Analysis - North America Tumor Ablation Market
